等待开盘 04-03 09:30:00 美东时间
+0.230
+0.51%
GEO Group reported lower Q1 revenue and adjusted EBITDA, missing consensus. EPS also fell short. Outlook raised for FY25 but Q2 expectations lowered.
2025-05-07 23:32
Shuttle Pharmaceuticals Holdings Inc. has announced an update to its clinical trial for the drug Ropidoxuridine, a radiation sensitizing agent. The company has entered into a change order with Therade...
2025-01-29 05:11
AZZ raises FY25 guidance due to strength in several end markets. Sales outlook increased to $1.525-$1.625B, adjusted EPS to $4.50-$5.00, and adjusted EBITDA to $310-$360M. Company plans to report Q4 results on April 22, 2024.
2024-04-08 20:43